Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
TCRT

Market Cap: $4.86M

AI

Alaunos Therapeutics, Inc.

TCRT

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin-340.00%

EBITDA Margin-1364.50%

EBIT Margin-1369.67%

Pre-tax Margin-1369.67%

Net Profit Margin-1369.67%

Earnings Yield-1.06%

Valuation Multiples

Price / Book3.01

Price / Sales1619.96

Price / Earnings-0.92

PEG-0.06

Forward PEG0.06

EV / Sales1501.96

EV / EBITDA-1.10

EV / Operating Cash Flow-1.44

EV / Free Cash Flow-1.40

Price / Free Cash Flow-1.51

Price / Operating Cash Flow-1.24

Cash Flow & Capital

Free Cash Flow / Share-$1.66

Operating Cash Flow / Share-$1.61

Free Cash Flow Yield-66.38%

Capex / Revenue32.67%

Capex / Operating Cash Flow-3.13%

Capex / Depreciation6.53

Stock Compensation / Revenue134.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.63

Quick Ratio1.63

Cash Ratio0.59

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.09

Solvency Ratio-6.88

Financial Leverage1.46

Efficiency & Working Capital

Asset Turnover0.00

Fixed Asset Turnover0.04

Inventory Turnover0.00

Receivables Turnover0.00

Payables Turnover2.56

Days Sales Outstanding0

Days Inventory Outstanding0

Days Payables Outstanding142.72

Operating Cycle0

Cash Conversion Cycle-142.72

Working Capital Turnover0.00

Returns & Quality

Return on Equity-1.66%

Return on Assets-2.18%

Return on Invested Capital-3.22%

ROCE-3.22%

Return on Tangible Assets-2.18%

Operating Return on Assets-1.71%

Income Quality0.76

Tax Burden1.00

Interest Burden1.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$4.51M

Invested Capital$457K

Working Capital$375K

Tangible Asset Value$1.29M

Net Current Asset Value$375K

Graham Net-Net-$0.12

Book Value / Share$0.66

Tangible Book Value / Share$0.66

Cash / Share$0.18

Financial Health Scores

Piotroski Score3

Altman Z-Score-690.23

Revenue$3K

EBIT$-4.11M

Market Cap$4.88M

Working Capital$375K

Retained Earnings$-925.63M

Total Assets$1.88M

Total Liabilities$595K